Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
KLXE
|
Geoffrey C Stanford
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,574 Reduced 5.46% |
$5,209
$3.31 p/Share
|
Apr 01
2025 |
|
BJ
|
Paul Cichocki
EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 24,896 Reduced 10.91% |
$2,860,052
$114.88 p/Share
|
Apr 01
2025 |
|
BJ
|
Paul Cichocki
EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 45,770 Added 17.46% |
-
|
Apr 01
2025 |
|
PRCH
|
Matt Ehrlichman
CEO, CHAIRMAN AND FOUNDER |
SELL
Payment of exercise price or tax liability
|
Direct | 6,820 Reduced 0.05% |
$48,967
$7.18 p/Share
|
Apr 01
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 9,472 Added 0.0% |
$60,810
$6.42 p/Share
|
Apr 01
2025 |
|
BBIO
|
Andrea Ellis |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 71.43% |
$1,021,499
$34.05 p/Share
|
Apr 01
2025 |
|
BBIO
|
Andrea Ellis |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 41.67% |
$253,499
$8.45 p/Share
|
Apr 01
2025 |
|
PII
|
Gwynne Shotwell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 740 Added 3.88% |
$30,613
$41.37 p/Share
|
Apr 01
2025 |
|
BJ
|
Anjana Harve
EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,787 Added 20.39% |
-
|
Apr 01
2025 |
|
BJ
|
Anjana Harve
EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,188 Reduced 7.87% |
$136,477
$114.88 p/Share
|
Apr 01
2025 |
|
PII
|
Gwenne A. Henricks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 740 Added 2.48% |
$30,613
$41.37 p/Share
|
Apr 01
2025 |
|
PII
|
Gary E Hendrickson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 861 Added 1.79% |
$35,619
$41.37 p/Share
|
Apr 01
2025 |
|
PII
|
George W Bilicic
Director |
BUY
Grant, award, or other acquisition
|
Direct | 846 Added 3.12% |
$34,999
$41.37 p/Share
|
Apr 01
2025 |
|
PII
|
Bernd F Kessler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 800 Added 1.59% |
$33,096
$41.37 p/Share
|
Apr 01
2025 |
|
BJ
|
Graham Luce
EVP, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 5,907 Reduced 31.03% |
$678,596
$114.88 p/Share
|
Apr 01
2025 |
|
BJ
|
Graham Luce
EVP, Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 9,693 Added 35.11% |
-
|
Apr 01
2025 |
|
MAA
|
Timothy Argo
EVP, Chief Strategy & Analysis |
BUY
Grant, award, or other acquisition
|
Direct | 1,185 Added 6.23% |
-
|
Apr 01
2025 |
|
MAA
|
Timothy Argo
EVP, Chief Strategy & Analysis |
SELL
Payment of exercise price or tax liability
|
Direct | 153 Reduced 0.91% |
$25,624
$167.48 p/Share
|
Apr 01
2025 |
|
PRCH
|
Matthew Neagle
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,152 Reduced 0.62% |
$58,531
$7.18 p/Share
|
Apr 01
2025 |
|
INTU
|
Sandeep Aujla
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,591 Reduced 42.08% |
$976,858
$613.99 p/Share
|
Apr 01
2025 |
|
INTU
|
Sandeep Aujla
EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,100 Added 45.05% |
-
|
Apr 01
2025 |
|
BJ
|
Monica Schwartz
EVP, Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 9,010 Reduced 33.83% |
$1,035,068
$114.88 p/Share
|
Apr 01
2025 |
|
BJ
|
Monica Schwartz
EVP, Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,307 Added 44.49% |
-
|
Apr 01
2025 |
|
WTW
|
Pamela Thomson Hall
Head of International |
SELL
Payment of exercise price or tax liability
|
Direct | 748 Reduced 12.93% |
$252,786
$337.95 p/Share
|
Apr 01
2025 |
|
WTW
|
Pamela Thomson Hall
Head of International |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 5 Added 0.09% |
-
|
Apr 01
2025 |
|
BJ
|
Joseph Mc Grail
SVP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 4,076 Reduced 24.95% |
$468,250
$114.88 p/Share
|
Apr 01
2025 |
|
BJ
|
Joseph Mc Grail
SVP, Controller |
BUY
Grant, award, or other acquisition
|
Direct | 7,350 Added 31.03% |
-
|
Apr 01
2025 |
|
AKYA
|
John Frederick Ek
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 16,432 Reduced 6.21% |
$22,183
$1.35 p/Share
|
Apr 01
2025 |
|
BGNE
|
Xiaobin Wu
President, COO & GM China |
SELL
Open market or private sale
|
Direct | 51,921 Reduced 100.0% |
$14,648,471
$282.13 p/Share
|
Apr 01
2025 |
|
BGNE
|
Xiaobin Wu
President, COO & GM China |
BUY
Exercise of conversion of derivative security
|
Direct | 51,921 Added 50.0% |
$7,642,251
$147.19 p/Share
|
Apr 01
2025 |
|
ST
|
Brian K Roberts
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,738 Reduced 2.46% |
$66,341
$24.23 p/Share
|
Apr 01
2025 |
|
ST
|
Brian K Roberts
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 51,074 Added 31.47% |
-
|
Apr 01
2025 |
|
KNSA
|
John F. Paolini
CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 991 Reduced 1.75% |
$21,574
$21.77 p/Share
|
Apr 01
2025 |
|
KNSA
|
John F. Paolini
CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,374 Added 5.62% |
-
|
Apr 01
2025 |
|
BX
|
Joseph Baratta |
BUY
Grant, award, or other acquisition
|
Direct | 67,207 Added 6.89% |
-
|
Apr 01
2025 |
|
REKR
|
Michael David Dunbar
Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 24,212 Reduced 10.85% |
$21,790
$0.9 p/Share
|
Apr 01
2025 |
|
BB
|
Tim Foote
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,080 Reduced 11.47% |
$6,968
$3.35 p/Share
|
Apr 01
2025 |
|
BB
|
Tim Foote
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,283 Added 29.47% |
-
|
Apr 01
2025 |
|
LHX
|
Robert B Millard
Director |
BUY
Grant, award, or other acquisition
|
Direct | 238 Added 2.39% |
$49,920
$209.75 p/Share
|
Apr 01
2025 |
|
MAA
|
Melanie Carpenter
EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct | 1,164 Added 5.11% |
-
|
Apr 01
2025 |
|
MAA
|
Melanie Carpenter
EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct | 152 Reduced 0.74% |
$25,456
$167.48 p/Share
|
Apr 01
2025 |
|
ST
|
Lynne J Caljouw
EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,184 Reduced 7.2% |
$149,838
$24.23 p/Share
|
Apr 01
2025 |
|
ST
|
Lynne J Caljouw
EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 25,326 Added 22.76% |
-
|
Apr 01
2025 |
|
KNSA
|
Ross Moat
CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 984 Reduced 3.66% |
$21,421
$21.77 p/Share
|
Apr 01
2025 |
|
KNSA
|
Ross Moat
CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,352 Added 11.08% |
-
|
Apr 01
2025 |
|
SQ
|
Mary G Meeker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 253 Added 0.06% |
-
|
Apr 01
2025 |
|
ZLAB
|
Joshua L Smiley |
BUY
Exercise of conversion of derivative security
|
Direct | 32,062 Added 29.87% |
-
|
Apr 01
2025 |
|
ZLAB
|
Rafael Amado |
BUY
Exercise of conversion of derivative security
|
Direct | 19,523 Added 27.94% |
-
|
Apr 01
2025 |
|
ZLAB
|
Yajing Chen
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,257 Added 33.16% |
-
|
Apr 01
2025 |
|
DLTR
|
Steven Schumacher
Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct | 11,614 Added 39.24% |
-
|
Apr 01
2025 |